Ong KJ, Desai S, Desai M, Nardone A, van Hoek AJ, Gill ON. Cost and cost-effectiveness of an HIV pre-exposure prophylaxis (PrEP) programme for high-risk men who have sex with men in England: results of a static decision analytical model. Lancet 2015; 386:S16....
NHS England's national director for specialized commissioning, John Stewart, added, "Not only did the trial directly prevent many cases of HIV, help normalize the use of PrEP, remove stigma and pave the way for a routinely commissioned clinically and cost effective PrEP service, but it also ma...
More information:Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.The Lancet Infectious Diseases. DOI:dx.doi.org/10.1016/S1473-3099(17)30540-6 Pre-exposure prophylaxis is cost-effective for...
This study was based on a subsample of 580 GBMSM self-reported as HIV negative/unknown sero-status. Results Of the participants, 82 (14.1%) and 37 (6.4%) had experience of SDU and chemsex in the past year. The prevalence of PrEP uptake was 4.0% among all participants and 14.6% among...
NHS England says it has reached agreement with manufacturers to keep the cost below a £10m budget. Trials have suggested PrEP, a daily pill which acts to disable HIV before it takes hold, can cut the risk of being infected by more than 80%. ...
Cost and coupons Descovy and alcohol Generic Interactions Pregnancy Birth control needs Breastfeeding How to take How it works FAQ Precautions Overdose Expiration Drug images Descovy is a brand-name oral tablet that’s prescribed to treat HIV and lower the risk of contracting HIV. Descovy contains ...
PrEP has been suggested to be the most cost-effective and promising way to decrease HIV incidence among at-risk MSM in previous modeling studies.32 The Clinical Screening Index was developed to prioritize individuals for PrEP use and is used by the U.S. CDC.20 Individuals who engaged in high...
offered by PrEP in HIV transmission, we strongly advocated for improved accessibility to PrEP among key populations by either reducing the cost of the medication or providing it free of charge. The multifactorial analysis conducted in this study (Fig.3) identified several associated factors within ...
To add to the complexity, it will also be important to consider whether PrEP become less cost-effective over time due to saturation and decreasing burden of new HIV infections necessitating the addition or increase of scale of other interventions. In light of these complexities, an on-going ...
which found that PrEP reduced HIV incidence by 86%, we now have very strong evidence on the efficiency and cost effectiveness of PrEP in the UK. Yet, despite this, those most at risk in the UK remain unable to access this important HIV prevention measure. As Dr Brady continues in response...